MDS/MPN Flashcards

1
Q

WHO Criteria for MDS

A
  • Refractory cytopenia of childhood (RCC)
    PB blasts <2%, BM blasts< 5%
  • Refractory cytopenia with excess blasts (RAEB)
    PB blasts 2-19%, BM 5-19%
  • Refractory cytopenia with excess blasts in transformation (RAEB_T)
    PB and/or BM blasts 20-29%
  • MDS/AML

Note that JMML and DS related TAM are separate categories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Major differences in adult vs childhood MDS

A
  • RCC often hypocellular in children

- RCC/RAEB can have stable counts for months/years. Median time to progression of RCC to RAEB is 5 y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Differential diagnosis of hypoplastic BM

A
  1. Infections: EBV, CMV, HSV, parvo, HIV
  2. Vitamin def (B12, folate)
  3. Metaboic (MVK deficiency)
  4. Rhuem
  5. Mitochondrial (Pearson)
  6. Inherited BMF syndrome (FA, DC, AMKT, TAR, etc)
  7. SAA
  8. RCC
  9. PNH
  10. Prephase to leukemia
  11. HLH
  12. lymphoproliferative disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common cytogenetic and molecular abnormalities

A

Cytogenetics:

  • Monosomy 7
  • Trisomy 8
  • complex karyoptype
  • 5q- is rare (common in adults)

Molecular

  • GATA 2
  • ETV6
  • RUNX1
  • CEBPA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

JMML criteria

A
  1. Clinical/Heme (all 4 mandatory)
    - monocyte count > 1
    - blast percentage < 20%
    - splenomegaly
    - absence of Ph chromosome
  2. Oncogentic (1 is sufficient)
    - somatic mutation in PTPN11 or k-ras or n-ras
    - clinical diagnosis of NF-1 or germline NF-1
    - germline CBL mutation and LOH in CBL
  3. For those without oncogenetic criteria, must have 2 of the following:
    - hypersensitivity to GM-CSF
    - monosomy 7 or other chromosomal abn
    - HbF increased
    - myeloid precursors in BM
    - hyperphosphorylation of STAT 5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prognostic factors in JMML

A

poor prognostic factors:

  • Age > 2
  • Hb F elevated> 10%
  • low plt count < 33
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mutations associated with JMML

A
N-ras
K-ras
PTPN-11
CBL
NF-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment options for JMML

A
  1. Germline n-ras/k-ras/ptpn-11 - Noonan’s related MPD so watch and wait
  2. Germline CBL also often self-resolve so watch and wait if well
  3. Germline NF-1 - HSCT
  4. Somatic PTPN-11 and k-ras or n-ras - HSCT
    * k-ras has high risk of relapse. n-ras less so in the absence of high-risk features may consider watch and wait
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Essential Thrombasthenia criteria

A
  • Plt > 450
  • BM wit mega proliferation and no increase in granulopoesis/erythropoesis
  • JAK2V617F or other clone
  • Absence of criteria for other MPN
  • no reactive cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly